Five notes:
1. Worldwide revenue was $40.3 million in the third quarter, a 19% increase year over year.
2. U.S. revenue was $38.3 million, an 18% increase year over year.
3. The company saw a net loss of $6.6 million.
4. There are more than 1,200 physicians in the U.S. using SI-Bone’s products in the third quarter, a 15% increase year over year.
5. SI-Bone also refinanced a $36 million term loan, lowered all-in borrowing costs and extended maturity to 2029.
